David Gentien
Inserm · 341 works · 7,338 citations · h-index 43
Top works
- Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial
- Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER)
- SF3B1 Mutations Are Associated with Alternative Splicing in Uveal Melanoma
- A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts
- Molecular profiling of patient-derived breast cancer xenografts
- Establishment and Characterization of a Panel of Human Uveal Melanoma Xenografts Derived from Primary and/or Metastatic Tumors
- Randomised proof-of-concept phase II trial comparing targeted therapy based on tumour molecular profiling vs conventional therapy in patients with refractory cancer: results of the feasibility part of the SHIVA trial
- Multi-factor data normalization enables the detection of copy number aberrations in amplicon sequencing data
- Distinctive roles of age, sex, and genetics in shaping transcriptional variation of human immune responses to microbial challenges
- Polo-like Kinase 1: A Potential Therapeutic Option in Combination with Conventional Chemotherapy for the Management of Patients with Triple-Negative Breast Cancer
- Letrozole and palbociclib versus chemotherapy as neoadjuvant therapy of high-risk luminal breast cancer
- TTK/hMPS1 Is an Attractive Therapeutic Target for Triple-Negative Breast Cancer
- Pyrophosphorolysis-Activated Polymerization Detects Circulating Tumor DNA in Metastatic Uveal Melanoma
- Balanced Translocations Disrupting SMARCB1 Are Hallmark Recurrent Genetic Alterations in Renal Medullary Carcinomas
- Designs and challenges for personalized medicine studies in oncology: focus on the SHIVA trial
- Establishment of novel cell lines recapitulating the genetic landscape of uveal melanoma and preclinical validation of mTOR as a therapeutic target
- Modulation of several waves of gene expression during FGF‐1 induced epithelial‐mesenchymal transition of carcinoma cells
- Modeling of response to endocrine therapy in a panel of human luminal breast cancer xenografts
- Mosaicism for oncogenic G12D KRAS mutation associated with epidermal nevus, polycystic kidneys and rhabdomyosarcoma
- High PTP4A3 Phosphatase Expression Correlates with Metastatic Risk in Uveal Melanoma Patients